Craniopharyngioma may have some impact on normal life expectancy, which needs to be analyzed according to the time of diagnosis of the tumor, the effect of treatment, and life care.
Craniopharyngioma belongs to benign neuroendocrine tumors, the etiology of which is still unclear. It can cause endocrine disruption in patients, leading to headache, nausea, vision loss and growth retardation. Craniopharyngioma is mainly treated by surgical resection, supplemented by radiotherapy, and hormone replacement therapy is needed for patients who cannot be surgically resected.
After complete surgical resection, craniopharyngioma generally does not affect normal life expectancy, patients who cannot be surgically removed or incomplete resection need to undergo long-term hormone replacement therapy, which will affect normal life expectancy to a certain extent, and go to the hospital for regular review according to the doctor’s instructions after the operation, and promptly deal with any discomforts found.